Clinical Trials on Protein in Australia
Total 378 results
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
Bayside HealthTerminated
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
GlaxoSmithKlineWithdrawn
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Peter MacCallum Cancer Centre, AustraliaMelbourne HealthCompleted
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompleted
-
Peter MacCallum Cancer Centre, AustraliaJanssen, LPRecruiting
-
Life Molecular Imaging SACompletedAlzheimer Disease | Amyloid Beta-ProteinAustralia
-
Cancer Trials AustraliaHuman Genome Sciences Inc.UnknownSymptomatic Waldenstroms MacroglobulinaemiaAustralia
-
Gilead SciencesTerminated
-
BayerTerminatedHemophilia A and BAustralia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
-
Peter MacCallum Cancer Centre, AustraliaJanssen-Cilag Ltd.CompletedMultiple MyelomaAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownHemophiliaNetherlands, Austria, Australia, Belgium, Canada, Finland, Germany, Italy, Spain, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaCompletedMultiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With LymphomaAustralia
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompletedMultiple Myeloma | Cutaneous LymphomaAustralia
-
Novartis PharmaceuticalsCompletedBone NeoplasmsAustralia
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina, Australia
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
Peter MacCallum Cancer Centre, AustraliaUnknownMultiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid LeukaemiaAustralia
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
FH Campus Wien, University of Applied SciencesMedical University of Vienna; ShireCompleted
-
Medical University of ViennaCompleted
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
Genentech, Inc.RecruitingMultiple MyelomaAustralia, Spain, Israel, Korea, Republic of, Greece, Norway, Denmark
-
Centre Leon BerardRecruitingCancer | Cancer Metastatic | ALK Fusion Protein Expression | FGFR2 Gene Translocation | FGFR3 Gene Translocation | NTRK Family Gene Mutation | Gene Fusion | ROS1 Gene Translocation | NTRK Gene Fusion Overexpression | ATIC-ALK Fusion Protein Expression | BCR-FGFR1 Fusion Protein Expression | COL1A1-PDGFB Fusion... and other conditionsFrance, Denmark, Netherlands, Austria, Germany, Italy, United Kingdom, Czechia, Poland, Slovenia, Spain
-
Medical University of GrazCompletedPatients on Long-term Proton Pump Inhibitor TherapyAustria
-
Austrian Forum Against CancerCompleted
-
Austrian Forum Against CancerCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Spark TherapeuticsChildren's Hospital of Philadelphia; University of Pittsburgh; St. James's Hospital... and other collaboratorsTerminated
-
Medical University InnsbruckCompleted
-
Melbourne HealthRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Plasma Cell Myeloma | Non-hodgkin Lymphoma | Leukemia, Lymphoblastic, Acute, L1 | Leukemia, Lymphoblastic, Acute, L2Australia
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia AUnited States, New Zealand, Australia, Hungary, Sweden, Austria, Poland, Romania
-
Medical University of ViennaSuspendedMultiple MyelomaAustria
-
Hoffmann-La RocheTerminated
-
rEVO BiologicsCompletedAntithrombin III DeficiencyUnited States, France, United Kingdom, Germany, Canada, Austria, Australia, Italy
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, Belgium, Spain, Japan, Poland, Australia
-
Tirol Kiniken GmbHLFB BIOMEDICAMENTSUnknown
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Australia, Taiwan, Czechia, Turkey, Ukraine, Netherlands, Italy, United Kingdom, Austria, Germany, Russian Federation
-
Bayside HealthMonash UniversityRecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | HIV | Chronic Lymphocytic Leukemia | Organ Transplantation | COVID-19 VaccinesAustralia
-
CSL BehringCompletedHemophilia BGermany, Australia, Italy, Israel, Czech Republic, Spain, France, Canada, Austria, Russian Federation